Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , IPO , cancer , drugs , Taiwan

   

Next In Business News

Thai business group cuts 2024 GDP growth forecast
TotalEnergies mulls moving listing to Wall St
Rig dearth aggravates Indonesia’s declining oil and gas production
Optimistic growth prospects for Focus Point Holdings
Epsom sees more student enrolment from UK
SC: Planners should give sound financial advice
China’s surging industrial loans aren’t going to its factories
Japan’s helping hand in BoE June rate cut window
Carsome turns Ebitda positive in 1Q24 on business scale
Cocoa-free chocolate maker raises US$52mil

Others Also Read